De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...

07 session he chaired entitled "ST Elevation Myocardial Infarction: The First 24 Hours." Dr. Smith: I'm Dr. Sidney Smith and with me is Dr. Elliott Antman, director of the Samuel A. Levine Cardiac ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

Among survivors of high-risk myocardial infarction, CV mortality has declined in recent years. The rate of cardiovascular (CV) mortality after high-risk myocardial infarction (MI) declined ...

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

The most common cause of a heart attack – the medical term is myocardial infarction (MI) – is a blocked coronary artery. The blockage cuts off oxygen-rich blood to an area of heart muscle ...

A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in ...

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

Myocardial infarction or 'heart attack' is a type of acute coronary syndrome in which sudden blockage of a coronary artery, and subsequent myocardial ischaemia, results in damage to the ...

For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...